US Equity
GERN
— GERON CORPORATIONGeron Corporation is a biopharmaceutical company that develops and commercializes therapeutics for hematologic malignancies using its telomerase inhibitor platform.
💰 Market cap: $949.45M📍 919 East Hillsdale Boulevard, Suite 250, FOSTER CITY, CA, 94404 US🏷️ Biotechnology & Medical Research💵 Previous close: $1.42🔢 6,770 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $1.42 |
| 2026-07-23 | $1.45 |
| 2026-07-22 | $1.41 |
| 2026-07-21 | $1.44 |
| 2026-07-20 | $1.44 |
| 2026-07-17 | $1.44 |
| 2026-07-16 | $1.42 |
| 2026-07-15 | $1.42 |
| 2026-07-14 | $1.38 |
| 2026-07-13 | $1.42 |
| 2026-07-10 | $1.50 |
| 2026-07-09 | $1.56 |
| 2026-07-08 | $1.56 |
| 2026-07-07 | $1.49 |
| 2026-07-06 | $1.44 |
| 2026-07-02 | $1.36 |
| 2026-07-01 | $1.27 |
| 2026-06-30 | $1.28 |
| 2026-06-29 | $1.30 |
| 2026-06-26 | $1.32 |
| 2026-06-25 | $1.37 |
| 2026-06-24 | $1.39 |
| 2026-06-23 | $1.35 |
| 2026-06-22 | $1.34 |
| 2026-06-18 | $1.26 |
| 2026-06-17 | $1.23 |
| 2026-06-16 | $1.18 |
| 2026-06-15 | $1.15 |
| 2026-06-12 | $1.15 |
| 2026-06-11 | $1.14 |
| 2026-06-10 | $1.10 |
| 2026-06-09 | $1.12 |
| 2026-06-08 | $1.13 |
| 2026-06-05 | $1.17 |
| 2026-06-04 | $1.21 |
| 2026-06-03 | $1.16 |
| 2026-06-02 | $1.17 |
| 2026-06-01 | $1.21 |
| 2026-05-29 | $1.25 |
| 2026-05-28 | $1.25 |
| 2026-05-27 | $1.26 |
| 2026-05-26 | $1.28 |
| 2026-05-22 | $1.28 |
| 2026-05-21 | $1.26 |
| 2026-05-20 | $1.26 |
| 2026-05-19 | $1.22 |
| 2026-05-18 | $1.23 |
| 2026-05-15 | $1.29 |
| 2026-05-14 | $1.40 |
| 2026-05-13 | $1.41 |
| 2026-05-12 | $1.40 |
| 2026-05-11 | $1.39 |
| 2026-05-08 | $1.39 |
| 2026-05-07 | $1.46 |
| 2026-05-06 | $1.58 |
| 2026-05-05 | $1.65 |
| 2026-05-04 | $1.57 |
| 2026-05-01 | $1.58 |
| 2026-04-30 | $1.54 |
| 2026-04-29 | $1.51 |
| 2026-04-28 | $1.51 |